Product Benefits
| Core Benefit | Mechanism |
| Synergistic Efficacy | Combines two complementary actions: Vildagliptin boosts glucose-dependent insulin release, and Metformin reduces liver glucose production and increases insulin sensitivity, leading to superior blood sugar lowering. |
| Enhanced $\text{A1c}$ Control | Provides a more robust reduction in average blood glucose levels ($\text{A1c}$) than either component used individually, helping patients reach and maintain target goals. |
| Convenient Single-Tablet Dosing | Consolidates two essential diabetes medications into one tablet, significantly improving patient compliance with the complex daily treatment regimen. |
| Low Inherent Hypoglycemia Risk | Both Vildagliptin and Metformin carry a low risk of causing hypoglycemia (low blood sugar) when used without sulfonylureas or insulin. |
⚠️ Important Safety Note: Combination Diabetes Tablet
Black Box Warning (Lactic Acidosis): Metformin carries a Black Box Warning for the rare but serious risk of lactic acidosis, especially in patients with kidney impairment.
7 Kidney function must be monitored regularly.Pancreatitis Risk: Vildagliptin has been associated with reports of acute pancreatitis.
8 Seek medical attention immediately if you develop severe, persistent abdominal pain.Prescription Required: This medication must be used strictly as prescribed and combined with diet and exercise. Do not crush, chew, or break the tablet.
Offer Products
Face Care
Hair Care
stationery & office
Tea & Coffee
Baby Wipes
Cream
Baby Essentials
Fragrances
Lip Care
Body Care
Air Freshener
Customer questions & answers
Customer reviews
0 out of 5